Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer

YOSHIHIKO MURATA, TOSHIO KOKURYO, YUKIHIRO YOKOYAMA, JUNPEI YAMAGUCHI, TOMOHIRO MIWA, MASATOSHI SHIBUYA, YOSHIHIKO YAMAMOTO and MASATO NAGINO
Anticancer Research February 2017, 37 (2) 589-598;
YOSHIHIKO MURATA
1Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSHIO KOKURYO
1Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kokuryoh@med.nagoya-u.ac.jp
YUKIHIRO YOKOYAMA
1Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JUNPEI YAMAGUCHI
1Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOHIRO MIWA
1Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASATOSHI SHIBUYA
2Department of Basic Medicinal Sciences, Nagoya University Graduate School of Pharmaceutical Sciences, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIHIKO YAMAMOTO
2Department of Basic Medicinal Sciences, Nagoya University Graduate School of Pharmaceutical Sciences, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASATO NAGINO
1Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 37 no. 2 589-598
PubMed 
28179305

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received November 24, 2016
  • Revision received December 25, 2016
  • Accepted January 9, 2017
  • Published online February 8, 2017.

Copyright & Usage 
Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. YOSHIHIKO MURATA1,
  2. TOSHIO KOKURYO1⇑,
  3. YUKIHIRO YOKOYAMA1,
  4. JUNPEI YAMAGUCHI1,
  5. TOMOHIRO MIWA1,
  6. MASATOSHI SHIBUYA2,
  7. YOSHIHIKO YAMAMOTO2 and
  8. MASATO NAGINO1
  1. 1Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
  2. 2Department of Basic Medicinal Sciences, Nagoya University Graduate School of Pharmaceutical Sciences, Nagoya, Japan
  1. Correspondence to Toshio Kokuryo, Division of Surgical Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. Tel: +81 527442222, Fax: +81 527442230, e-mail: kokuryoh{at}med.nagoya-u.ac.jp
View Full Text

Cited By...

  • 16 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 37 (2)
Anticancer Research
Vol. 37, Issue 2
February 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer
YOSHIHIKO MURATA, TOSHIO KOKURYO, YUKIHIRO YOKOYAMA, JUNPEI YAMAGUCHI, TOMOHIRO MIWA, MASATOSHI SHIBUYA, YOSHIHIKO YAMAMOTO, MASATO NAGINO
Anticancer Research Feb 2017, 37 (2) 589-598;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer
YOSHIHIKO MURATA, TOSHIO KOKURYO, YUKIHIRO YOKOYAMA, JUNPEI YAMAGUCHI, TOMOHIRO MIWA, MASATOSHI SHIBUYA, YOSHIHIKO YAMAMOTO, MASATO NAGINO
Anticancer Research Feb 2017, 37 (2) 589-598;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • In Vitro Elucidation of Drug Combination Synergy in Treatment of Pancreatic Ductal Adenocarcinoma
  • Google Scholar

More in this TOC Section

  • Anti-tumor Effect of Activated Canine B Cells With Interleukin-21 and Anti-B Cell Receptor
  • Claudin-10 in the Blood Brain Barrier Function of Cerebral Endothelial Cells and Transendothelial Invasion of Breast Cancer Cells
  • Development of Genetically Engineered Feeder Cells for Natural Killer Cell Expansion
Show more Experimental Studies

Similar Articles

Keywords

  • α-Bisabolol derivatives
  • AKT
  • pancreas cancer
  • peritoneal dissemination
  • apoptosis
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire